Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN83567338Phase 2Completed
Phase 2, randomised, double-blind trial in delirium comparing Haloperidol with Placebo (2 arms). Primary endpoint: Delirium/coma-free days. Started Oct 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN83567338.